Literature DB >> 15181248

A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity.

Ling Guo1, Mary Jo LaDu, Linda J Van Eldik.   

Abstract

Chronically activated glia associated with amyloid plaques might contribute to neuronal dysfunction in Alzheimer's disease (AD) through generation of neuroinflammatory molecules. Apolipoprotein E (apoE), also found associated with amyloid plaques, has been hypothesized to serve an anti-inflammatory role in the CNS through its ability to modulate beta-amyloid (Abeta)-induced glial activation. To further characterize the effect of apoE on inflammation, we examined the ability of exogenously added human apoE3 and apoE4 to modulate neuro inflammatory responses of cultured rat glia. Apolipoprotein E3 (apoE3) and apoE4 suppressed oligomeric Abeta-induced production of inducible nitric oxide synthase and cyclo-oxygenase-2, supporting an anti- inflammatory role for apoE. Exogenous apoE also inhibited Abeta-induced production of endogenous apoE. However, exogenous apoE in the absence of Abeta stimulated production of the pro-inflammatory cytokine interleukin-1beta in an isoform-dependent manner, with apoE4 inducing a significantly greater response than apoE3. These data support the idea that Abeta stimulation of glial apoE limits neuroinflammation but that overproduction of apoE by activated glia might exacerbate inflammation. In addition, the observation that apoE4 has more robust pro-inflammatory activity than apoE3 provides a mechanistic link between the APOE4 allele and AD, and suggests potential apoE-based therapeutic strategies. Copyright 2004 Humana Press Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181248     DOI: 10.1385/JMN:23:3:205

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  33 in total

1.  Glia and Alzheimer's disease.

Authors:  L J Van Eldik
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

2.  Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.

Authors:  K R Bales; T Verina; D J Cummins; Y Du; R C Dodel; J Saura; C E Fishman; C A DeLong; P Piccardo; V Petegnief; B Ghetti; S M Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes.

Authors:  J Hu; F Castets; J L Guevara; L J Van Eldik
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

Review 4.  Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression.

Authors:  W S Griffin; J G Sheng; M C Royston; S M Gentleman; J E McKenzie; D I Graham; G W Roberts; R E Mrak
Journal:  Brain Pathol       Date:  1998-01       Impact factor: 6.508

Review 5.  Lipoproteins in the central nervous system.

Authors:  M J Ladu; C Reardon; L Van Eldik; A M Fagan; G Bu; D Holtzman; G S Getz
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

Review 6.  Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease.

Authors:  B T Hyman; D Strickland; G W Rebeck
Journal:  Arch Neurol       Date:  2000-05

7.  Apolipoprotein E receptors mediate the effects of beta-amyloid on astrocyte cultures.

Authors:  M J LaDu; J A Shah; C A Reardon; G S Getz; G Bu; J Hu; L Guo; L J van Eldik
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

Review 8.  The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease.

Authors:  U Beffert; M Danik; P Krzywkowski; C Ramassamy; F Berrada; J Poirier
Journal:  Brain Res Brain Res Rev       Date:  1998-07

9.  Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

Authors:  Karie N Dahlgren; Arlene M Manelli; W Blaine Stine; Lorinda K Baker; Grant A Krafft; Mary Jo LaDu
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

Review 10.  ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.

Authors:  Arlene M Manelli; W Blaine Stine; Linda J Van Eldik; Mary Jo LaDu
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

View more
  71 in total

1.  Islet adaptation to obesity and insulin resistance in WNIN/GR-Ob rats.

Authors:  Himadri Singh; Sireesha Ganneru; Venkata Malakapalli; Maniprabha Chalasani; Giridharan Nappanveettil; Ramesh R Bhonde; Vijayalakshmi Venkatesan
Journal:  Islets       Date:  2014       Impact factor: 2.694

2.  ApoE4-dependent Abeta-mediated neurodegeneration is associated with inflammatory activation in the hippocampus but not the septum.

Authors:  Haim Belinson; Daniel M Michaelson
Journal:  J Neural Transm (Vienna)       Date:  2009-04-16       Impact factor: 3.575

Review 3.  Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease.

Authors:  Evan Dorey; Nina Chang; Qing Yan Liu; Ze Yang; Wandong Zhang
Journal:  Neurosci Bull       Date:  2014-03-20       Impact factor: 5.203

4.  An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines.

Authors:  I Dafnis; A K Tzinia; E C Tsilibary; V I Zannis; A Chroni
Journal:  Neuroscience       Date:  2012-03-14       Impact factor: 3.590

5.  Gene sequences regulating the production of apoE and cerebral palsy of variable severity.

Authors:  Espen Lien; Guro L Andersen; Yongde Bao; Heather Gordish-Dressman; Jon Skranes; James A Blackman; Torstein Vik
Journal:  Eur J Paediatr Neurol       Date:  2014-04-18       Impact factor: 3.140

6.  Identification and modification of amyloid-independent phenotypes of APOE4 mice.

Authors:  Amanda M DiBattista; Sonya B Dumanis; Joshua Newman; G William Rebeck
Journal:  Exp Neurol       Date:  2016-04-14       Impact factor: 5.330

7.  A derangement of the brain wound healing process may cause some cases of Alzheimer's disease.

Authors:  Steven Lehrer; Peter H Rheinstein
Journal:  Discov Med       Date:  2016-08       Impact factor: 2.970

8.  Apolipoprotein E polymorphisms and severity of cerebral palsy: a cross-sectional study in 255 children in Norway.

Authors:  Espen Lien; Guro L Andersen; Yongde Bao; Heather Gordish-Dressman; Jon S Skranes; Torstein Vik; James A Blackman
Journal:  Dev Med Child Neurol       Date:  2013-02-05       Impact factor: 5.449

9.  Hippocampal infusions of apolipoprotein E peptides induce long-lasting cognitive impairment.

Authors:  Donnie Eddins; Rebecca C Klein; Jerrel L Yakel; Edward D Levin
Journal:  Brain Res Bull       Date:  2009-01-29       Impact factor: 4.077

10.  Polymorphism in apolipoprotein E among migraineurs and tension-type headache subjects.

Authors:  Ravi Gupta; Vivek Kumar; Kalpana Luthra; Basudeb Banerjee; Manjeet Singh Bhatia
Journal:  J Headache Pain       Date:  2009-01-31       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.